Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group

Pistamaltzian, Nikolaos; Tzannis, Kimon; Pissanidou, Vassiliki; More

Anti-Cancer Drugs . 27(1):48-53, January 2016.

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies

Rixe, Olivier; Puzanov, Igor; LoRusso, Patricia M.; More

Anti-Cancer Drugs . 26(7):785-792, August 2015.

Gosha-jinki-gan reduced oxaliplatin-induced hypersensitivity to cold sensation and its effect would be related to suppression of the expression of TRPM8 and TRPA1 in rats

Kato, Yoshinori; Tateai, Yoshikazu; Ohkubo, Misao; More

Anti-Cancer Drugs . 25(1):39-43, January 2014.

Reduced folate and serum vitamin metabolites in patients with rectal carcinoma: an open-label feasibility study of pemetrexed with folic acid and vitamin B12 supplementation

Stoffregen, Clemens C.; Odin, Elisabeth A.; Carlsson, Göran U.; More

Anti-Cancer Drugs . 27(5):439-446, June 2016.

Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma

Baldi, Giacomo G.; Di Donato, Samantha; Fargnoli, Rossana; More

Anti-Cancer Drugs . 27(9):908-913, October 2016.

Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution

Ujike, Takeshi; Uemura, Motohide; Kawashima, Atsunari; More

Anti-Cancer Drugs . 27(10):1038-1043, November 2016.

5-Fluorouracil degradation rate could predict toxicity in stages II–III colorectal cancer patients undergoing adjuvant FOLFOX

Onesti, Concetta E.; Botticelli, Andrea; La Torre, Marco; More

Anti-Cancer Drugs . 28(3):322-326, March 2017.

Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas

Aspeslagh, Sandrine; Stein, Mark; Bahleda, Rastilav; More

Anti-Cancer Drugs . 28(3):341-349, March 2017.

Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A

Akbari, Bahman; Farajnia, Safar; Zarghami, Nosratollah; More

Anti-Cancer Drugs . 28(3):263-270, March 2017.